How to Turn $25,000 Into $250,000 From Monthly Dividends
Turning $25,000 into $250,000 may sound like a stretch, but for long-term investors focused on monthly dividends and steady reinvestment, it's very possible. It doesn't require picking high-risk stocks or gambling on fast gains. Instead, it takes three simple ingredients: solid dividend payers, time, and consistency. By investing in stocks like Dream Industrial REIT (TSX:DIR.UN), iShares S&P/TSX Composite High Dividend Index ETF (TSX:XEI), and Northland Power (TSX:NPI), Canadians can build a plan that turns passive income into lasting wealth.
Let's begin with Dream Industrial REIT. It's one of the more consistent real estate investment trusts (REIT) on the TSX, owning a portfolio of high-demand industrial properties across Canada, the U.S., and Europe. These buildings support the logistics and e-commerce sectors, making them critical infrastructure in today's economy.
The dividend stock trades around $11.50 and offers a $0.70 dividend, coming out monthly at a 6% yield. In its most recent earnings report, the dividend stock reported revenue of $159 million and net income of $118 million. It also maintained an impressive 98% occupancy rate. This steady income, combined with reinvestment, helps build a dividend-compounding foundation.
Next up is the iShares S&P/TSX Composite High Dividend Index ETF. This exchange-traded fund (ETF) holds a basket of high-yielding Canadian dividend stocks across multiple sectors, including financials, telecom, and utilities. That diversification spreads risk and smooths out returns.
As of writing, it trades around $28.25 and yields approximately 5.5%. The ETF distributes income monthly, and that cash flow can be easily reinvested. Over the last few years, XEI has offered a total return near 7% annually, making it a stable addition to any income portfolio.
Lastly, there's Northland Power, a renewable energy company that generates electricity from wind, solar, and natural gas. It's a strong player in the clean energy space with projects in Europe, North America, and Latin America. The dividend stock trades around $21.50 and pays a monthly dividend of $0.10 per share, or $1.20 annually for a 5.5% yield.
In its most recent quarter, Northland reported sales of $634 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $400 million. It also confirmed steady progress on major projects in Colombia and Germany, which could boost future cash flow. What makes Northland appealing is the mix of current income and the potential for long-term growth as the world transitions to renewables.
So how does this all come together? You could invest $10,000 in Dream Industrial, $10,000 in iShares XEI, and $5,000 in Northland Power. If you reinvest every dollar and continue adding when possible, that income compounds. Over time, you buy more shares, which then pay more dividends, and the cycle continues.
With consistent reinvestment, a $25,000 portfolio could double every 10 years, according to the rule of 72. After about 30 years, it could grow beyond $250,000 with dividends reinvested, all while providing regular monthly income. And unlike growth-only stocks, this strategy lets you benefit from passive cash flow every step of the way.
Of course, no investment is without risk. Dream Industrial relies on strong leasing markets. Northland Power depends on energy prices and project execution. And ETFs like XEI are exposed to broader market movements. But together, these stocks offer a blend of stability, income, and potential growth.
The post How to Turn $25,000 Into $250,000 From Monthly Dividends appeared first on The Motley Fool Canada.
Before you buy stock in Dream Industrial REIT, consider this:
The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Dream Industrial REIT wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.
Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $24,927.94!*
Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 30 percentage points since 2013*.
See the Top Stocks * Returns as of 6/23/25
More reading
Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS]
Market Volatility Toolkit
Best Canadian Stocks to Buy in 2025
Beginner Investors: 4 Top Canadian Stocks to Buy for 2025
5 Years From Now, You'll Probably Wish You Grabbed These Stocks
Subscribe to Motley Fool Canada on YouTube
Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends Dream Industrial Real Estate Investment Trust. The Motley Fool has a disclosure policy.
2025
擷取數據時發生錯誤
登入存取你的投資組合
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
There May Be Some Bright Spots In Attika Group's (Catalist:53W) Earnings
Investors were disappointed with the weak earnings posted by Attika Group Ltd. (Catalist:53W ). While the headline numbers were soft, we believe that investors might be missing some encouraging factors. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Zooming In On Attika Group's Earnings Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. This ratio tells us how much of a company's profit is not backed by free cashflow. As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking. Attika Group has an accrual ratio of 0.25 for the year to June 2025. Unfortunately, that means its free cash flow fell significantly short of its reported profits. In the last twelve months it actually had negative free cash flow, with an outflow of S$711k despite its profit of S$2.57m, mentioned above. It's worth noting that Attika Group generated positive FCF of S$5.9m a year ago, so at least they've done it in the past. Having said that, there is more to the story. We can see that unusual items have impacted its statutory profit, and therefore the accrual ratio. One positive for Attika Group shareholders is that it's accrual ratio was significantly better last year, providing reason to believe that it may return to stronger cash conversion in the future. Shareholders should look for improved cashflow relative to profit in the current year, if that is indeed the case. See our latest analysis for Attika Group Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Attika Group. The Impact Of Unusual Items On Profit Attika Group's profit suffered from unusual items, which reduced profit by S$946k in the last twelve months. If this was a non-cash charge, it would have made the accrual ratio better, if cashflow had stayed strong, so it's not great to see in combination with an uninspiring accrual ratio. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Attika Group to produce a higher profit next year, all else being equal. Our Take On Attika Group's Profit Performance In conclusion, Attika Group's accrual ratio suggests that its statutory earnings are not backed by cash flow, even though unusual items weighed on profit. Given the contrasting considerations, we don't have a strong view as to whether Attika Group's profits are an apt reflection of its underlying potential for profit. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. When we did our research, we found 4 warning signs for Attika Group (2 are a bit unpleasant!) that we believe deserve your full attention. In this article we've looked at a number of factors that can impair the utility of profit numbers, as a guide to a business. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Plurilock Security Inc. Reports Second Quarter Fiscal 2025 Financial Results
Management will host a conference call on Wednesday, August 20, 2025, at 11am ET 159% increase in Critical Services revenue year-over-year 42% improvement in Adjusted EBITDA loss year-over-year Second half to benefit from seasonal budget flows and ongoing strategic initiatives Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - Plurilock Security Inc. (TSXV: PLUR) (OTCQB: PLCKF) ("Plurilock" or the "Company"), a global cybersecurity services and solutions provider, announces its financial results for the three and six-months ended June 30, 2025 ("Q2 2025"). All dollar figures are stated in Canadian dollars, unless otherwise indicated. "In Q2, we continued to grow our Critical Services business," said Ian L. Paterson, CEO of Plurilock. "While a one-time, lower-margin resale order impacted overall margins this quarter, our strategy of margin expansion, led by Critical Services, remains strong. Recent meetings with top cybersecurity leaders and officials in Ottawa, Brussels, and at Black Hat reinforce our credibility and underscore the unprecedented levels of allied government investment in cyber and defense, areas where Plurilock is uniquely positioned to capture a meaningful share." Q2 2025 Financial Highlights Total revenue for the three and six months ended June 30, 2025, was $16,404,963 and $35,445,577 as compared to $14,305,546 and $27,140,854 for the three and six months ended June 30, 2024. Revenue for the three and six months ended June 30, 2025, is significantly higher comparative as a result of the timing on a few large orders, and significant growth in professional services along with revenue recognition of software over time. Hardware and systems sales revenue for the three and six months ended June 30, 2025, totalled $1,350,705 and $4,070,937 compared to $2,167,319 and $3,529,551 respectively in the comparative period ended June 30, 2024. Software, license, and maintenance sales revenue for the three and six months ended June 30, 2025, was $10,785,841 and $23,367,659 compared to $10,492,062 and $20,557,340 in the comparative period. Professional services revenue was $4,268,417 and $8,006,981 for the three and six months ended June 30, 2025, compared to $1,646,165 and $3,053,963 in the three and six months ended June 30, 2024. Hardware and systems sales revenues for the three and six months ended June 30, 2025, accounted for 8.2% and 11.5%, respectively, of total revenues compared to 15.2% and 13.0%, respectively, for the three and six months ended June 30, 2024. Software, license and maintenance sales revenues for the three and six months ended June 30, 2025, accounted for 65.7% and 65.9%, respectively, compared to 73.3% and 75.7%, respectively, for the three and six months ended June 30, 2024. Professional services revenue for the three and six months ended June 30, 2025, accounted for 26.0% and 22.6%, respectively, of total revenues, compared to 11.5% and 11.3%, respectively, for the three and six months ended June 30, 2024. Gross margin for the three and six months ended June 30, 2025, was 12.0% and 12.1% compared to 14.7% and 14.4% for the three and six months ended June 30, 2024. Adjusted EBITDA for the three and six months ended June 30, 2025, was $(1,400,359) and $(2,675,180) compared to $(2,422,291) and $(1,643,193) during the same period in the prior year. Cash and cash equivalents and restricted cash on June 30, 2025, was $1,739,643 compared to $1,419,463 on December 31, 2024. The Company has an additional $8,547,804 in unused credit facilities. During the three and six months ended June 30, 2025, the Company generated $47,795 and used $5,087,345 of cash from operating activities compared to $1,552,516 and $1,973,631 use of cash during the same periods in the prior year. Q2 2025 Operational Highlights April 2, 2025: $5.9 Million in new contracts across several Federal and Public Sector Clients April 16, 2025: Presenting at Planet MicroCap and Attending RSAC(TM) 2025 Conference April 17, 2025: Corporate Update - Strategic Focus, Sector Strength, and Margin Expansion May 1, 2025: Plurilock Security Inc. Reports Fiscal 2024 Financial Results June 2, 2025: Plurilock Security Inc. Reports Record First Quarter Fiscal 2025 Financial Results June 5, 2025: $1.3M in New Critical Services Contracts Across U.S. Commercial Clients June 25, 2025: Results of Annual General Meeting June 26, 2025: $2.54 Million CAD Sale to NASDAQ-Listed Enterprise for AI Cybersecurity Subsequent to Q2 2025 Operational Highlights July 10, 2025: Plurilock Named Certified Services Partner for Forcepoint Outlook Plurilock reiterates its 2025 growth strategy focused on higher margin offerings, led by Critical Services, and maintaining a strong liquidity profile. The Company continues to build a healthy pipeline across enterprise, defense, and public sector markets, with line of sight to second-half activity benefiting from seasonal budget flows and ongoing strategic initiatives. These opportunities are driven by trusted client relationships, partner pull-through, and targeted business development aimed at securing multi-year, recurring contracts. Internationally, Plurilock is advancing into NATO, Middle East, and other non-U.S. defense markets, leveraging its track record with Canadian and U.S. federal clients to enter NATO-aligned markets and pursue joint defense bids with major integrators. Recent meetings with senior public sector cybersecurity leaders and procurement officials in Ottawa and Brussels reinforced Plurilock's credibility and positioning to benefit from unprecedented levels of allied government cyber and defense spending. These initiatives align with the Company's proven approach, starting with smaller, high-trust Critical Services engagements and expanding into multi-year, enterprise-scale contracts. The Company's balance sheet remains stable, with cash on hand and unused credit capacity providing sufficient liquidity. The Company has also made improvements in how working capital is managed, shortening payment terms with key customers, pulling forward cash, and tightening contractor payments. At the same time, the Company is more selective on which federal sales opportunities we pursue, reallocating resources to higher-margin Critical Services and commercial opportunities. Combined with changes in revenue recognition and a more selective, strategic bidding approach, these shifts are smoothing revenue and supporting healthier margins over time. Q2 2025 Financial Results Webinar Details Plurilock's CEO Ian L. Paterson and CFO Scott Meyers will host a live webinar on Wednesday, August 20, 2025, at 11am ET to review the results, provide Company updates and answer investor questions following the presentation. Date: Wednesday, August 20, 2025 Time: 11am ET / 8am PT Webinar: Register A recording of the webinar and supporting materials will be made available on the investor relations page of the Company's website. Summary of Key Financial Metrics Three months ended June 30, Six months ended June 30, Restated-Note 26 Restated-Note 26 2025 2024 2025 2024 $ $ $ $ Revenue 16,404,963 14,305,546 35,445,577 27,140,854 Hardware and systems sales 1,350,705 2,167,319 4,070,937 3,529,551 Software, license and maintenance sales10,785,841 10,492,062 23,367,659 20,557,340 Professional services 4,268,417 1,646,165 8,006,981 3,053,963 Gross margin (%) 12.0% 14.7% 12.1% 14.4% Net loss for the period (2,230,829 )(3,733,983 )(5,243,192 )(5,536,232 ) Basic and diluted loss per share - for the period(0.03 )(0.10 )(0.07 )(0.27 ) EBITDA(1) (1,945,546 )(3,416,800 )(4,104,462 )(4,576,128 ) Reconciliation of EBITDA: Net loss for the period (2,230,829 )(3,733,983 )(5,243,192 )(5,536,232 ) Foreign exchange translation gain/(loss)89,039 (36,779 )679,992 86,206Amortization 46,730 81,416 149,238 186,272Interest expenses 139,670 262,485 299,656 679,144Impairment on assets - 1,579 - - Adjusted EBITDA(1) (1,400,359 )(2,422,291 )(2,675,180 )(1,643,193 ) Reconciliation of adjusted EBITDA: EBITDA(1) (1,945,546 )(3,416,800 )(4,104,462 )(4,576,128 ) Stock-based compensation 209,093 377,959 433,435 438,798Financing expenses 15,550 215,285 241,367 219,128Acquisition-related expenses 41,609 87,975 108,552 92,255Investor relations 278,935 313,290 647,597 365,284Loss (gain) on disposal of assets- - - 1,817,470 June 30,2025 December 31,2024 $ $ Cash and cash equivalents 1,719,643 1,399,463 Restricted cash 20,000 20,000 Total current assets 25,092,452 30,510,681 Total assets 28,681,606 34,473,190 Total current liabilities 30,986,804 39,266,753 Total liabilities 31,341,919 39,614,489 Weighted average common shares outstanding (millions)78.5 37.5 Note: (1) Non-GAAP measure. Earnings before interest, taxes, depreciation, and amortization ("EBITDA") and Adjusted EBITDA should not be construed as alternatives to net income/loss determined in accordance with IFRS. EBITDA and Adjusted EBITDA do not have any standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers. The Company defines EBITDA as earnings before interest, taxes, and amortization. Adjusted EBITDA is defined as EBITDA before stock-based compensation, financing, and acquisition related expenses. The Company believes that EBITDA and Adjusted EBITDA is a meaningful financial metric for investors as it adjusts income to reflect amounts which the Company can use to fund working capital requirements, service future interest and principal debt repayments and fund future growth initiatives. Non-IFRS measures This news release presents information about EBITDA and Adjusted EBITDA, both of which are non-IFRS financial measures, to provide supplementary information about operating performance. Plurilock defines EBITDA as net income or loss before interest, income taxes, depreciation, and amortization. Adjusted EBITDA removes non-cash share-based compensation, financing, investor relations and acquisition-related expenses from EBITDA. The Company believes that EBITDA and Adjusted EBITDA is a meaningful financial metric for investors as it adjusts income to reflect amounts which the Company can use to fund working capital requirements, service future interest and principal debt repayments and fund future growth initiatives. EBITDA and Adjusted EBITDA are not intended as a substitute for IFRS measures. A limitation of utilizing these non-IFRS measures is that the IFRS accounting effects of the adjustments do in fact reflect the underlying financial results of Plurilock's business and these effects should not be ignored in evaluating and analyzing Plurilock's financial results. Therefore, management believes that Plurilock's IFRS measures of net loss and the same respective non-IFRS measure should be considered together. Non-IFRS measures do not have any standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Readers should refer to the Company's most recently filed MD&A for a more detailed discussion of these measures and their calculations. Quarterly Filings Management's Discussion and Analysis and Interim Condensed Consolidated Financial Statements and the notes thereto for the fiscal period ended June 30, 2025, can be obtained from Plurilock's corporate website at and under Plurilock's SEDAR+ profile at About Plurilock Plurilock is a services-led, product-enabled, AI-native cybersecurity company that solves complex cyber problems in high-stakes environments where failure isn't an option. Trusted by Five-Eyes governments, NATO-aligned agencies, and Global 2000 enterprises, we defend critical infrastructure and safeguard the systems that power modern life. Our Critical Services division delivers operational resilience through unmatched expertise, proprietary IP, and AI-driven playbooks. For more information, visit or contact: Ian L. PatersonChief Executive Officerian@ Ali HakimzadehExecutive Chairmanali@ Sean PeasgoodInvestor Relationssean@ Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the TSX Venture Exchange policies) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This press release may contain certain forward-looking statements and forward-looking information (collectively, "forward-looking statements") related to future events or Plurilock's future business, operations, and financial performance and condition. Forward-looking statements normally contain words like "will", "intend", "anticipate", "could", "should", "may", "might", "expect", "estimate", "forecast", "plan", "potential", "project", "assume", "contemplate", "believe", "shall", "scheduled", and similar terms. Forward-looking statements are not guarantees of future performance, actions, or developments and are based on expectations, assumptions, and other factors that management currently believes are relevant, reasonable, and appropriate in the circumstances. Although management believes that the forward-looking statements herein are reasonable, actual results could be substantially different due to the risks and uncertainties associated with and inherent to Plurilock's business. Additional material risks and uncertainties applicable to the forward-looking statements herein include, without limitation, the impact of general economic conditions, and unforeseen events and developments. This list is not exhaustive of the factors that may affect the Company's forward-looking statements. Many of these factors are beyond the control of Plurilock. All forward-looking statements included in this press release are expressly qualified in their entirety by these cautionary statements. The forward-looking statements contained in this press release are made as at the date hereof, and Plurilock undertakes no obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by applicable securities laws. Risks and uncertainties about the Company's business are more fully discussed under the heading "Risk Factors" in its most recent Annual Information Form. They are otherwise disclosed in its filings with securities regulatory authorities available on SEDAR+ at To view the source version of this press release, please visit Sign in to access your portfolio
Yahoo
13 minutes ago
- Yahoo
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
CAMBRIDGE, Mass., Aug. 19, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases. This collaboration will be based on XtalPi's intelligent and automated drug discovery platform, which integrates artificial intelligence (AI), quantum physics, and large-scale automated robotic experiments. The two companies plan to co-identify targets and discover first-in-class or best-in-class drug candidates using XtalPi's proprietary AI-driven drug discovery platform. The XtalPi platform combines the speed and generative power of AI with the accuracy of its robotic lab-in-the-loop to accelerate drug discovery and vastly expand the explorable chemical space. This integrated workflow spans deep-learning-based molecule design, quantum physics and molecular dynamics simulations for predicting drug-target interactions, automated chemical synthesis, and experimental validation of candidate compounds' key pharmaceutical properties. Leveraging its expertise in immunology and inflammation as well as its experience in small molecule drug development, Dong-A ST will actively participate throughout the entire R&D process—including candidate validation, efficacy and safety testing, and the formulation of preclinical and clinical development strategies. The company also plans to explore strategies for pipeline expansion and assess commercialization potential. Through this partnership, Dong-A ST aims to strengthen its pipeline in the immunology and inflammation space and expand its R&D scope beyond small molecule therapeutics into areas such as targeted protein degradation (TPD), biologics, antibody-drug conjugates (ADC), and gene therapies. John Wang, Senior Vice President of Drug Discovery at XtalPi, stated: "The combination of Dong-A ST's extensive expertise and XtalPi's proven AI-robotics platform is well-positioned to translate scientific innovation into competitive precision medicines. Together, we aim to rapidly discover and rigorously validate novel drug candidates across multiple modalities to unlock unique market opportunities, and deliver transformative therapies for global patients." Jae-Hong Park, Head of R&D at Dong-A ST, remarked, "This collaboration marks a pivotal step in expanding Dong-A ST's R&D capabilities," adding, "By leveraging synergies with XtalPi's AI platform, we expect to accelerate the development of next-generation treatments for immune and inflammatory diseases." Meanwhile, both Dong-A ST and XtalPi operate open innovation offices in Boston, USA. This geographic proximity will facilitate closer and more efficient collaboration throughout the drug discovery process. About Dong-A ST Dong-A ST Co., Ltd. ( was established in 1932 and is a leading Korean pharmaceutical company engaged in the development, manufacturing, and commercialization of ethical drugs, biosimilars, medical devices, and diagnostics. Its key products include Stillen (gastritis), Zydena (erectile dysfunction), Motilitone (functional dyspepsia), and Imuldosa (ustekinuma biosimilar). Leveraging strong R&D capabilities and a history of innovation, Dong-A ST is expanding its pipeline in immunology, inflammation, neurological disease, metabolic diseases, and oncology, while advancing into new modalities such as biologics, ADCs, TPD, and gene therapies. About XtalPi XtalPi Holdings Limited (XtalPi, was founded in 2015 by three physicists from the Massachusetts Institute of Technology (MIT). It is an innovative R&D platform powered by quantum physics, artificial intelligence, and robotics. By integrating first-principles calculations, AI algorithms, high-performance cloud computing, and standardized automation systems, XtalPi provides digital and intelligent R&D solutions for companies in the pharmaceutical, materials science, agricultural technology, energy, new chemicals, and cosmetics industries. View original content to download multimedia: SOURCE XtalPi Inc. Sign in to access your portfolio
